,

Camallergy
View On Demand

Life-Changing Treatments For The Tens of Millions Suffering From Food Allergies

About the Event


Camallergy has developed an innovative treatment for the more than 6 million people in the U.S. and Europe who live with peanut allergies. Their oral immunotherapy provides protection to patients within 14 weeks of treatment.  It’s a game-changing treatment that:

  • Achieved best-in-class results in over 300 children treated in an early access clinic and phase 2 trial
  • Is unanimously preferred by allergists over the current treatment option
  • Enhanced by a novel medical device to dramatically improve patient and physician experience
  • Is a platform technology that extends to other food allergies

Join our webinar with Camallergy CEO, Sherden Timmins to hear more about how the company plans to have this cutting-edge treatment ready for Phase 3 Clinical Trials in 2023 and commercial launch in 2026.

View On-Demand


SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.